93167-96-5

Basic information

• Product Name: N~2~-(4-bromophenyl)-1,3,5-triazine-2,4,6-triamine
• CAS NO: 93167-96-5
• Molecular Formula: C₉H₉BrN₆
• Molecular Weight: 281.112
• Mol File: 93167-96-5.mol

Chemical Properties

• Boiling Point: 542.2°C at 760 mmHg
• Flash Point: 281.7°C
• Density: 1.803g/cm³
• Vapor Pressure: 8.06E-12mmHg at 25°C
• Refractive Index: 1.79
• CAS DataBase Reference: N~2~-(4-bromophenyl)-1,3,5-triazine-2,4,6-triamine(CAS DataBase Reference)
• NIST Chemistry Reference: N~2~-(4-bromophenyl)-1,3,5-triazine-2,4,6-triamine(93167-96-5)
• EPA Substance Registry System: N~2~-(4-bromophenyl)-1,3,5-triazine-2,4,6-triamine(93167-96-5)

Safety Data

• Hazardous Substances Data: 93167-96-5(Hazardous Substances Data)

Upstream product

• 3397-62-4 2-Chloro-4,6-diamino-1,3,5-triazine 
• 106-40-1 4-bromo-aniline 

Relevant articles and documents

Fluorescence and morphology modulation in a photochromic diarylethene self-assembly system

Switchable supramolecular self-assemblies on the basis of interaction between melamine group containing photochromic diarylethene unit (DTE) and naphthalimide derivate (1) were designed and fabricated. 1 can gelate several aprotic solvents with different morphologies. The gel turned into partial gel in ethyl acetate with the addition of DTE as a guest molecule. Both the absorption and fluorescence spectra of the assembly can be reversibly switched by alternating UV/visible light irradiation. Meanwhile, the morphology of the coassembly of 12·DTE changed to film from original pieces of gel 1 in ethyl acetate. When 12·DTE was irradiated by UV light, the film morphology was converted into aggregated flakes. Moreover, the surface wettability of the complex can also be switched by light irradiation. The photochromic diarylethene unit is able to modulate the fluorescence and morphology of the assembled system only by virtue of light irradiation. Therefore, these results provide further insights into fluorescence and morphology controlling, especially application in upscale smart responsive materials.

1,3,5-TRIAZINE-2,4,6-TRIAMINE COMPOUND OR PHARMACEUTICAL ACCEPTABLE SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

Disclosed herein are a 1,3,5-triazine-2,4,6-triamine compound or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a composition for preventing or treating metabolic syndromes, diabetes, or cancers with deletion of P53 gene, wh